# Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response

> **NCT02126384** · NA · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 9 (actual)

## Conditions studied

- Pneumococcal Diseases

## Interventions

- **DRUG:** pneumovax vaccination

## Key facts

- **NCT ID:** NCT02126384
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-18
- **Primary completion:** 2016-04
- **Final completion:** 2016-04-05
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02126384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02126384, "Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02126384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*